Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience 

Similar presentations


Presentation on theme: "Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience "— Presentation transcript:

1 Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience  Sameh Gaballa, MD, Rima Saliba, PhD, Jonathan E. Brammer, MD, Gary Lu, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, MD, Fabian Bock, MD, Chitra Hosing, MD, Uday R. Popat, MD, Ruby Delgado, Gabriela Rondon, MD, Jatin Shah, Elisabet Manasanch, MD, Robert Z. Orlowski, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD  Biology of Blood and Marrow Transplantation  Volume 21, Issue 2, (February 2015) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure Progression free survival.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience "

Similar presentations


Ads by Google